These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11363799)

  • 1. Two new protease inhibitors approved by FDA. Food and Drug Administration.
    Folkers G
    NIAID AIDS Agenda; 1996 Mar; ():4-5. PubMed ID: 11363799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration.
    Schouten JT
    STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New drugs for HIV infection.
    Med Lett Drugs Ther; 1996 Apr; 38(972):35-7. PubMed ID: 8606677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three days that shook the world.
    Gilden D; Smart T
    GMHC Treat Issues; 1996 Mar; 10(3):1-5. PubMed ID: 11363388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease inhibitors-at-a-glance.
    Notes Undergr; 1996 Apr; (no 32):4-5. PubMed ID: 11363449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on HIV protease inhibitors.
    Vella S
    AIDS Clin Care; 1995 Oct; 7(10):79-82, 88. PubMed ID: 11362832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Freedom of choice.
    Vazquez E
    Posit Aware; 1996; 7(3):9, 19. PubMed ID: 11363432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highlights from the FDA antiviral drug advisory committee meetings, February 27-March 1, 1996.
    Baker R
    BETA; 1996 Mar; ():7-13. PubMed ID: 11363321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease inhibitors shine in triple combinations.
    AIDS Alert; 1996 Mar; 11(3):31-2. PubMed ID: 11363243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kids studies.
    Treat Rev; 1995 Nov; (no 20):7. PubMed ID: 11363029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indinavir (Crixivan).
    Treat Rev; 1996 Apr; (no 21):7. PubMed ID: 11363398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efavirenz DuPont Pharmaceuticals Co.
    Dong BJ
    IDrugs; 1998 Oct; 1(6):700-11. PubMed ID: 18465625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease inhibitors: patient education critical.
    James JS
    AIDS Treat News; 1996 Apr; (no 244):1-3. PubMed ID: 11363303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on protease inhibitors.
    Cheng B
    PI Perspect; 1996 Apr; (no 18):5-7. PubMed ID: 11363512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abbott laboratories files New Drug Application for ritonavir.
    J Int Assoc Physicians AIDS Care; 1996 Jan; 2(1):35. PubMed ID: 11363329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease inhibitor trials moving to next phase.
    AIDS Alert; 1995 Aug; 10(8):100-1. PubMed ID: 11362675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ritonavir: first to prolong survival.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):38-44. PubMed ID: 11363517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment for primary infection.
    Smart T
    GMHC Treat Issues; 1995 Dec; 9(12):1, 3-4. PubMed ID: 11362994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conference looks at HIV drug resistance.
    Chang HE
    GMHC Treat Issues; 1995 Sep; 9(9):6-8. PubMed ID: 11362910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Merck protease inhibitor: more news from Retroviruses Conference.
    James JS
    AIDS Treat News; 1996 Feb; (no 241):1-3. PubMed ID: 11363186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.